Skip to main content
. 2010 Sep 7;4(9):e814. doi: 10.1371/journal.pntd.0000814

Table 3. Incidence of adverse events recorded in 1,210 pediatric patients treated with meglumine antimoniate.

Parameter Frequency (%)
Decrease of hemoglobin 20
Hyperamylasemia 10
Hypokalemia 7
ECG modifications 6
Hyponatremia 2
Nefrotoxicity 2
Liver enzyme (ALT) increase 1